Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EBT (2020 - 2025)

iSpecimen has reported EBT over the past 6 years, most recently at -$2.7 million for Q4 2025.

  • For Q4 2025, EBT rose 55.17% year-over-year to -$2.7 million; the TTM value through Dec 2025 reached -$9.0 million, up 30.19%, while the annual FY2025 figure was -$9.0 million, 30.19% up from the prior year.
  • EBT for Q4 2025 was -$2.7 million at iSpecimen, up from -$2.8 million in the prior quarter.
  • Over five years, EBT peaked at $30538.0 in Q4 2021 and troughed at -$6.0 million in Q4 2024.
  • A 5-year average of -$2.4 million and a median of -$2.3 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: soared 102.02% in 2021 and later crashed 7172.11% in 2022.
  • Year by year, EBT stood at $30538.0 in 2021, then crashed by 7172.11% to -$2.2 million in 2022, then crashed by 30.96% to -$2.8 million in 2023, then crashed by 111.96% to -$6.0 million in 2024, then soared by 55.17% to -$2.7 million in 2025.
  • Business Quant data shows EBT for ISPC at -$2.7 million in Q4 2025, -$2.8 million in Q3 2025, and -$1.8 million in Q2 2025.